BioCryst Pharmaceuticals
Katy Burnett is an accomplished finance executive with extensive experience in the biotechnology and healthcare sectors. Currently serving as Senior Vice President of Finance and Accounting at BioCryst Pharmaceuticals, Inc., Katy has previously held prominent finance roles at Novo Nordisk, Forma Therapeutics, Akebia Therapeutics, bluebird bio, and Abiomed. Katy's career at GE Healthcare spanned over 15 years, where various roles included Controller for multiple divisions and positions in financial management and auditing. Educational credentials include an MBA in Finance and Accounting from Marquette University, an Honors Bachelor of Arts from McMaster University, and a third-year study abroad program at Seinan Gakuin University.
This person is not in any offices